Friday, July 10, 2026

pharma · Gout · Asthma

Sunshine Guojian Pharmaceutical

Sunshine Guojian Pharmaceutical is a pharma organization headquartered in FORT LAUDERDALE, FL, CN. Primary therapeutic focus areas include Gout, Asthma, Type 2 Diabetes, Dermatitis, Atopic, Chronic Hepatitis C. NovaPharm

FORT LAUDERDALE, FL, CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
FORT LAUDERDALE, FL, CN
Programs
165
Drugs
80
Patents
121
Clinical program

Rongliflozin

Phase 1 · small molecule · Type 2 Diabetes Mellitus

Rongliflozin for Type 2 Diabetes Mellitus is a Phase 1 program (small_molecule) at Sunshine Guojian Pharmaceutical (Shanghai) Co., with 1 ClinicalTrials.gov record(s).

Internal code DJT1116PG-DM-108

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Phase
Phase 1
Modality
small_molecule
Indication
Type 2 Diabetes Mellitus
Status
completed
Trials
1

Clinical trials